Biotech Startups
10,037 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Orgenesis provides decentralized manufacturing infrastructure for cell and gene therapies, enabling on-site processing of CGTs in regional centers through its POCare™ platform and OMPUL™ mobile processing units. The company aims to reduce costs, shorten development timelines, and improve patient access to personalized cell and gene therapies.
0 investors
0 investors
0 investors
Origin Life Sciences is a clinical-stage biotechnology company developing IonoJet, a patented high-energy plasma device that generates and delivers a nitric oxide plasma stream to targeted areas of the body. Its therapy is being developed for chronic wound healing, skin and soft tissue infections, and other indications including dermatology, infection control, podiatry, and dentistry.
0 investors
Oro Muscles develops muscle intelligence technology that analyzes movement data to provide actionable insights for athletes, coaches, and healthcare providers in sports and rehabilitation settings. The company combines biomechanical analysis with AI to support decision-making in athletic performance and value-based care.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
ODI (OrthoDriven) develops AI-driven fluoroscopic imaging hardware and software for orthopedic surgeons, including its FreeCT technique that produces real-time 2D and 3D imaging of hard and soft tissue for surgical planning, intervention, and evaluation. Its product line includes surgical and clinical imaging units for musculoskeletal, extremity, and needle-guidance procedures.
0 investors
0 investors
Osmol Therapeutics is a preclinical-stage biotech developing OSM-0205, an intravenous drug intended to prevent chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI) in cancer patients receiving taxane-based therapy. The drug targets the interaction that triggers a calcium surge leading to neuronal damage, aiming to allow optimal chemotherapy dosing.
0 investors
OssiFi develops small molecule therapeutics targeting bone growth modulation, specifically focusing on inhibiting Wnt pathway regulators to treat conditions like osteoporosis. The company leverages established drug development technologies and manufacturing expertise to advance candidates through clinical development.
0 investors
OsteoNovus develops medical device solutions for orthopedic surgery, leveraging its NovoGro technology platform for spinal and orthopedic applications. The company serves orthopedic surgeons and patients requiring surgical interventions.
0 investors
0 investors
0 investors
Otomagnetics develops a non-invasive magnetic injection system to deliver drugs and therapeutic payloads to the inner and middle ear, the eye, and the skin, aimed at treating conditions such as inner ear diseases. The technology has demonstrated drug delivery to the inner and middle ear in animal models without puncturing the eardrum.
0 investors
0 investors
0 investors